Cessatech A/S (NGM:CESSA)

Sweden flag Sweden · Delayed Price · Currency is SEK · Price in DKK
11.16
+0.46 (4.30%)
At close: Jul 24, 2025
4.30%
Market Cap311.00M
Revenue (ttm)1.81M
Net Income (ttm)-23.64M
Shares Out18.58M
EPS (ttm)-1.36
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,981
Average Volume16,052
Open10.70
Previous Close10.70
Day's Range10.68 - 11.22
52-Week Range6.00 - 19.20
Beta0.52
RSI41.94
Earnings DateAug 21, 2025

About Cessatech

Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S... [Read more]

Industry Pharmaceutical Preparations
Founded 2020
Employees 4
Stock Exchange Nordic Growth Market
Ticker Symbol CESSA
Full Company Profile

Financial Performance

Financial numbers in DKK Financial Statements

News

There is no news available yet.